Glutathione inhibits HIV replication by acting at late stages of the virus life cycle

AIDS Research and Human Retroviruses

Volumn 12, Issue 16, 1996, Pages 1537-1541

  Palamara, Anna Teresa ^a   Perno, Carlo Federico ^a   Aquaro, Stefano ^a   Buè, Maria Cristina ^a   Dini, Luciana ^b   Garaci, Enrico ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE;

ANTIVIRAL ACTIVITY; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0029861402     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1537     Document Type: Article

References (23)

1. Roederer M, Staal FJT, Raju PA, Ela SW, Herzenberg LA, and Herzenberg LA: Cytokine-stimulated HIV replication is inhibited by N-acetylcysteine. Proc Natl Acad Sci USA 1990;87:4884-4888.
2. Kalebic T, Kinter A, Poli G, Anderson ME, Meister A, and Fauci AS: Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester and N-acetylcysteine. Proc Natl Acad Sci USA 1991;88: 986-990.
3. Staal F, Roederer MA, Herzenberg A, and Herzenberg L: Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87:9943-9947.
4. Schreck R, Rieber P, and Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991;10: 2247-2258.
5. Nabel G and Baltimore D: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 1987;326:711-713.
6. Palamara AT, Perno CF, Ciriolo MR, Dini L, Balestra E, D'Agostini C, Di Francesco P, Favalli C, Rotilio G, and Garaci E: Evidence for antiviral activity of glutathione: In vitro inhibition of herpes simplex virus type 1 replication. Antiviral Res 1995;27: 237-253.
7. Garaci E, Palamara AT, Di Francesco P, Favalli C, Ciriolo MR, and Rotilio G: Glutathione inhibits replication and expression of viral proteins in cultured cells infected with Sendai virus. Biochem Biophys Res Commun 1992;188:1090-1096.
8. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-362.
9. Perno CF and Yarchoan R: Culture of HIV in monocytes and macrophages. In: Current Protocols in Immunology (Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, and Strober W, Eds.). John Wiley & Sons, New York, 1993, pp. 12.4.1-12.4.11.
10. 2: Induction of heat shock protein synthesis and alteration of protein glycosylation. Antiviral Res 1992;19:129-138.
11. Mihm S, Ennen J, Pessara U, Kurth R, and Droge W: Inhibition of HIV-1 replication and NF-κB activity by cysteine and cysteine derivatives. AIDS 1991;5:497-503.
12. Schreck R, Meier B, Männel DN, Dröge W, and Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 1992;175:1181-1194.
13. Israël N, Gougerot-Pocidalo MA, Aillet F, and Virelizier JL: Redox status of cells influences constitutive or induced NF-κB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J Immunol 1992;149:3386-3393.
14. Mihm S, Gaiter D, and Droge W: Modulation of transcription factor NF-κB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J 1995;9: 246-252.
15. Vidal S, Mottet G, Kolakofsky D, and Roux L: Addition of high-mannose sugars must precede disulfide bond formation for proper folding of Sendai virus glycoproteins. J Virol 1989;63:892-900.
16. Lukacs N, Thiel H-J, Mettenleiter TC, and Rziha H-J: Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex. J Virol 1985;53:166-173.
17. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, and Gregory TJ: Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp 120) expressed in Chinese hamster ovary cells. J Biol Chem 1990; 265:10373-10386.
18. Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, and Capon DJ: Delineation of a region of the human immunodeficiency virus type-1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987;50: 975-985.
19. Staal FJ, Roederer M, Raju PA, Anderson MT, Ela SV, Herzenberg A, and Herzenberg L: Antioxidants inhibit stimulation of HIV transcription. AIDS Res Hum Retroviruses 1993;9:299-306.
20. Witschi A, Junker E, Schranz C, Speck RF, and Lauterburg BH: Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS. AIDS Res Hum Retroviruses 1995;1:141-143.
21. Palamara AT, Garaci E, Rotilio G, Ciriolo MR, Casabianca A, Fraternale A, Rossi L, Schiavano GF, Chiarantini L, and Magnani M: Inhibition of murine AIDS by reduced glutathione. AIDS Res Hum Retroviruses 1996;12:1373-1381.
22. Morse HC III, Chattopadhyay SK, Makino M, Fredrickson TN, Hugin AW, and Hartley JW: Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 1992;6:607-621.
23. Palamara AT, Nucci C, Buè C, and Gavaci E: Efficacy of glutathione on experimental HSV-1 keratitis. In preparation.